New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome June 29, 2026
OCCI Showcases Commercial Opportunities at the Egyptian-Saudi International Franchise Exhibition July 2, 2026